Jackson, P
Celgene Corporation San Diego USA
2 papers on CoChatORCID 0000-0002-2796-5297
Most cited papers
- Verified
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
Lopez-Girona, A., Mendy, D., Ito, T., Miller, K., Gandhi, A. K., Kang, J., Karasawa, S., Carmel, G., Jackson, P., Abbasian, M., et al. (2012) · Leukemia
Protein Degradation and InhibitorsMultiple Myeloma Research and Treatments
Cited by 814
- Verified
Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity
Gandhi, A. K., Mendy, D., Waldman, M., Chen, G., Rychak, E., Miller, K., Gaidarova, S., Ren, Y., Wang, M., Breider, M., et al. (2014) · British Journal of Haematology
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 106
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free